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Objectives: To investigate medication nonadherence in heart and/or lung transplant recipients; 
to explore patients’ opinions about their medications and transplant experience; and to investigate 
strategies used to facilitate adherence.
Methods: A semi-structured questionnaire was developed to address the objectives of this 
exploratory study. Face-to-face interviews were conducted with inpatients and clinic outpatients 
at a large public teaching hospital.
Results: Thirty three patients consented to participate. Sixteen (48.5%) admitted to having 
missed a dose of their immunosuppressant medications at some time since the transplant, with 
ﬁ  ve (15.2%) missing a dose in the two weeks prior to data collection. The main reasons for 
missing doses were ‘forgetfulness’ (n = 16, 48.5%) or ‘being busy with other things’ (9, 27.3%). 
Most nonadherence was unintentional, only 4 (12.1%) ever chose not to take a dose. Participants 
had strong opinions about their medications and condition. Most had a positive feeling towards 
their transplant and all had positive feelings about the team. Reported reasons for adherence 
included increased life span and quality of life. All but one of the participants used strategies 
or aids to facilitate adherence.
Conclusions: Self-reported nonadherence rates identiﬁ  ed were low compared with literature 
reports for adherence in chronic disease and in other transplant populations. Participants’ opin-
ions about their medications and transplant experience may have acted as a strong motivator 
for adherence.
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Introduction
Goals of medication therapy are often undermined by poor patient adherence. Causes 
of nonadherence to a prescribed treatment regimen are variable throughout different 
disease states (Rovelli et al 1989). They include factors associated with the patient, 
such as patient beliefs (Greenstein and Siegal 1998; Horne and Weinman 1999), disease 
severity (Ostrop et al 2000; Dunbar-Jacob and Mortimer-Stephens 2001), difﬁ  culty 
remembering a dose (Greenstein and Siegal 1998; Ostrop et al 2000); the treatment 
regimen, including difﬁ  cult (Ostrop et al 2000; Dunbar-Jacob and Mortimer-Stephens 
2001) or inconvenient (Sketris et al 1994) dosage regimens, number of medications 
(Kiley et al 1993; Meyers et al 1996); and the patient’s relationships with their family 
members (De Geest et al 1995) and their physicians (Kiley et al 1993; Raiz et al 
1999). Factors speciﬁ  c to adherence to immunosuppressant therapy in heart and/or 
lung transplant recipients have been reported in a recent review and include socioeco-
nomic, condition, therapy, and patient-related factors (De Geest et al 2005). Horne and 
Weinman (1999) found that for patients with chronic illness, beliefs about medications 
were a stronger predictor of adherence than clinical or sociodemographic factors.
There is evidence that adherence to medication is a critical requirement 
for the success of an organ transplant (Ostrop et al 2000; Kiley et al 1993; Patient Preference and Adherence 2008:2 116
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De Geest et al 1995; Raiz et al 1999). Though recent 
evidence has indicated that a successful organ transplant 
can occur for up to 5 years without immunosuppres-
sive therapy (Alexander et al 2008; Kawai et al 2008; 
Scandling et al 2008). Frequent omission of immuno-
suppressant medications results in adverse clinical out-
comes (Meyers et al 1996), such as rejection episodes, 
decreased quality of life, organ loss, and possibly death 
(Rovelli et al 1989; Kiley et al 1993; De Geest et al 
1995; Greenstein and Siegal 1998; Dew et al 1999; 
Chisholm et al 2001). Increased healthcare costs are also 
a consequence of poor adherence (Dunbar-Jacob and 
Mortimer-Stephens 2001; Chisholm et al 2001) due to 
the costs associated with performing the transplant and 
dealing with the rejection episode, as well as the loss of 
the organ resource (Rovelli et al 1989).
Most transplant recipients take between 5 and 20 differ-
ent medications, with over 50% of these dosed three to four 
times a day (SVH 2002). Studies have shown the prevalence 
of nonadherence to immunosuppressant medications to 
be as high as 75% (Kiley et al 1993; De Geest et al 1995; 
Greenstein and Siegal 1998). While the prevalence ranges 
from 25% (Dew et al 1996) to 36% (Dew et al 1999) in 
heart transplant recipients, with reports of approximately 
23% (Teichman et al 2000) and 37% (Matthees et al 2001) 
in lung transplant recipients.
Patients who report less than perfect adherence may 
beneﬁ  t from the use of strategies to facilitate adherence. 
These strategies need to be targeted at a speciﬁ  c cause of 
nonadherence within a particular patient group (Frazier 
et al 1994; Dunbar-Jacob and Mortimer-Stephens 2001). 
However, a greater understanding of factors associated with 
nonadherence is needed prior to the development of any 
interventions (Raiz et al 1999).
The majority of studies in the area of medication adher-
ence in solid organ (SO) transplant recipients have been con-
ducted in kidney transplant recipients with only a few studies 
on heart (Rovelli et al 1989; Schweizer et al 1990; Dew et al 
1996, 1999) or lung (Teichman et al 2000; Matthees et al 
2001) transplant recipients. This can be attributed to kidney 
transplants being more common than any other SO transplant 
(Chisholm 2002).
Therefore, the aims of this study were to: investigate 
medication nonadherence in lung and/or heart transplant 
(LHTX) recipients; explore patients’ opinions about their 
immunosuppressant (IS) medications, condition and trans-
plant experience; and investigate strategies used by patients 
to facilitate adherence.
Methods
An exploratory study was designed and conducted at a large 
public teaching hospital in Sydney, which has one of the 
largest heart and lung transplant programs in the world (SVH 
2002). St Vincent’s Hospital is one of the two heart/lung 
transplant centers in South-Eastern Australia. Approximately 
45–50 transplants are performed each year. All patients 
(hospital in-patients post transplant and patients attending 
routine ambulatory clinic visits) who had undergone a LHTX 
and were being treated at the hospital during the study period 
were eligible. Patients who could not speak English and who 
were physically unable to participate were excluded. Written 
consent was obtained from all participants who were will-
ing to take part in the study. Approval for the conduct of the 
study was obtained from the institution’s Human Research 
Ethics Committee.
As the primary study aim was exploratory, no sample 
size calculation was performed; patients were recruited until 
“saturation” in the data was reached, that is, until no new 
themes or information were identiﬁ  ed from the interview 
data (Quine 1998). Each eligible patient attending the hos-
pital or clinic in the ﬁ  ve-week study period was approached 
and invited to participate. In-patients were approached on 
the ward. Out-patients were approached in the waiting 
room of the heart and lung transplant clinic while they 
waited for a scheduled appointment. It is routine for all 
in-patients (even from day one when extubated) to keep 
and be responsible for taking their own medications. This 
is to ensure that they are able to manage their medications 
when discharged.
Instrument
Nonadherence, patient opinions and strategies used were 
assessed using a questionnaire delivered by an independent 
researcher, during a 20 minute face-to-face interview. An 
interview can be a reliable method for nonadherence assess-
ment as long as the questions are asked in a nonthreatening 
and supportive manner by an independent investigator. The 
questionnaire’s face and content validity were assessed using 
four researchers with a healthcare background and a small 
group of patients.
The questionnaire, consisting of open and closed ques-
tions, was developed, by adapting relevant questions from 
validated questionnaires (Frazier et al 1994; Greenstein and 
Siegal 1998; Horne and Weinman 1999; Kory 1999; Svarstad 
et al 1999; Bultman and Svarstad 2000; Ostrop et al 2000). 
It was designed for verbal responses using printed answer 
cards for the closed questions with multiple responses to Patient Preference and Adherence 2008:2 117
Medical adherence among heart and/or lung transplant recipients
facilitate understanding and easier responding (Kiley et al 
1993; Horne and Weinman 1999).
Patients were questioned about their adherence to medi-
cations since their transplant, and in the two weeks prior 
to the interview. This shorter recall period is thought to 
reduce reporting error (Svarstad et al 1999). Patients were 
questioned about their opinions towards their IS medications, 
their condition, their feelings towards the transplant process, 
team (surgeons, doctors, pharmacists, and nurses) and expe-
rience, as possible factors affecting medication adherence 
(Kiley et al 1993; Horne and Weinman 1999; Raiz et al 1999; 
Chisholm et al 2001); and devices or strategies used to aid 
adherence. For the purposes of this study adherence was 
deﬁ  ned as an ‘all or nothing’ principle a practice supported 
by previous research (Greenstein and Siegal 1998).
Data analysis
Data were entered into SPSS (Statistical Package for the 
Social Sciences; SPSS Inc., Chicago, IL, USA) for Win-
dows, Version 10, and analyzed descriptively. Open ques-
tions were content-analyzed thematically (Weber 1990). 
The responses were ﬁ  rst numerically coded into categories, 
which were assessed for themes or patterns. Those categories 
with similar themes were linked together, and the responses 
interpreted.
Nonparametric Mann-Whitney U test for two indepen-
dent samples was used to test for differences between the 
in-patient and out-patient groups. For the purposes of this 
study, responses from all subjects were grouped together, 
irrespective of their transplant, as the study was exploratory 




Thirty-three out of the 34 patients approached agreed to 
participate. Twenty-two (66.7%) were out-patients. The 
average age of the sample was 45 years (range: 16–71). 
Twenty-one (63.6%) were male and 29 (87.9%) were Cau-
casian. Twelve (36.4%) patients were employed, 11 (33.3%) 
were not working, and 10 (30.3%) were retired. Over half 
(54.5%) had reached year 10 or less at school, with 27.2% 
having completed tertiary education.
The majority of patients (n = 21, 63.6%) had received 
a single or double lung transplant, with 10 and 2 receiv-
ing a heart, and heart and lung transplant, respectively. 
The average time since transplant was 51.5 months 
(range: 0.8–142); and since any alteration had been made to 
the medication regimen was 53.5 days (range: 0–330). The 
number of medications taken is shown in Table 1.
No statistically significant differences were found 
between the in-patient and out-patient groups when com-
paring patient characteristics or adherence. Therefore, the 
responses from the two groups were combined.
Adherence to immunosuppressant 
medication
Sixteen (48.5%) participants admitted to having missed 
one dose of their medications at some stage since receiv-
ing their transplant: one subject admitted that this occurred 
once a week; three reported missing one dose once a month, 
with the remainder missing one dose less than once every 
6 months. Over the two weeks prior to data collection, 15.2% 
of participants admitted missing one dose, but the majority 
of this was unintentional.
‘Forgetfulness’ (48.5%) or ‘being busy with other 
things’ (27.3%) were the common causes of missed dose 
(Table 2). No respondent indicated that they had ever missed 
Table 1 Number of medications, and medication doses per day, in 
medication regimen for the subjects
 Self-reported 
  Mean number  Mean number
  of medications  of doses per day
Total medications  10.8  16.1
 (SD  = 3.71)  (SD = 6.59)
Immunosuppressant 2.9  4.7
Medications (SD  = 0.13)  (SD = 0.89)
Table 2 Reasons for missed doses (n = 16)*
Reason for missed dose  Frequency (n)  Relative 
   frequency  (%)
Forget medication  16  100.0
Busy with other things  9  56.3
Running out of medication  5  31.3
Away from home  4  25.0
Difﬁ  cult scheduling medication  4  25.0
taking around food
Choose not to take it  4  25.0
Too many medications to take  3  18.8
Misplaced medication  2  12.5
Belief that medication is not working  2  12.5
Sick of taking medications  2  12.5
Due to side effects caused  2  12.5
Notes: *The responses are not mutually exclusive. The data presented are the 
frequency and relative frequency (%); calculation based on n = 16 (total number of 
respondents who admitted to missing a dose).Patient Preference and Adherence 2008:2 118
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a dose because they felt healthy. Of the 24 recipients who 
indicated that at least one of their medications bothered 
them in some way, only 2 had ever missed a dose as a 
result.
Patient opinions
All participants agreed or strongly agreed that they would 
only be able to keep their transplanted organ if they took 
their medications and that they should never delay or miss 
their medications (Table 3).
All participants had positive feelings towards the transplant 
team, while 31 (93.9%) had a positive feeling towards their 
transplant, with the reasons given falling into three broad cat-
egories. Firstly, the majority reported that their positive attitude 
could be attributed to their increased life span, due to the success 
of the transplant. Patients felt that they had a ‘second chance’ at 
life because they were ‘still alive’. An increased quality of life 
also contributed to their positive feelings, as the participants ‘felt 
better’ and could literally ‘breathe easier’ after receiving their 
transplant. A small number indicated that their transplant gave 
them the chance to spend more time with family and friends 
and see ‘children and grandchildren grow up’.
Strategies to facilitate adherence
Nearly all (32) of the participants used at least one device or 
strategy to facilitate adherence (Table 4). Fifty-eight percent 
of the sample had a family member or friend helping them 
with their medications, either by reminding them to take 
them, or helping ‘organize’ their medications (ie, ‘setting 
up the pill box’, ‘getting medications ready’, or obtaining 
repeat prescriptions).
Discussion
This study described medication adherence and opinions 
about immunosuppressant medications, condition and the 
transplant experience in lung and/or heart transplant recipi-
ents, and investigated strategies used by patients to facilitate 
adherence.
A low level of self-reported nonadherence was seen in 
this study, as over half of the participants had ‘never’ missed 
a dose of their IS medications since receiving their transplant. 
The level of nonadherence seen in the two weeks prior to 
Table 3 Patients’ opinions towards their medications and condition (n = 33)




















The medications I take for my 
organ should never be delayed 
or missed.
00 0 62 7
0 0 0 18.2 81.8
I will only be able to keep my 
organ if I take my medications.
00 0 52 8
0 0 0 15.2 84.8
If I don’t take my medications 
correctly my condition will get 
worse.
00 2 92 2
0 0 6.1 27.3 66.7
Taking my medications 
correctly will prolong my life.
00 1 82 4
0 0 3 24.2 72.7
I need to take my medications 
for the rest of my life.
00 0 72 6
0 0 0 21.2 78.8
I believe that my condition is 
serious.
04 2 52 2
0 12.1 6.1 15.2 66.7
Notes: The data presented are the frequency and relative frequency (%); calculation based on n = 33 (total number of respondents).
Table 4 Strategies or devices used to facilitate adherence (n = 33)*
Strategy/device Frequency  (n)  Relative
   frequency  (%)
Obvious placement   30  90.9
of medication(s)
Dosette box  14  42.4
Webster pack  2  6.1
Written list  14  42.4
The blue book  16  48.5
Messages/Post it notes  2  6.1
Alarm 9  27.3
Family member/friend  19  57.6
Notes: *The responses are not mutually exclusive. The data presented are the 
frequency and relative frequency (%); calculation based on n = 33 (total number of 
respondents).Patient Preference and Adherence 2008:2 119
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the study interview was lower than levels reported in the 
literature for heart transplant recipients, where nonadher-
ence has been reported to range from 25% (Dew et al 1996; 
Kory 1999) to 36% (Dew et al 1999). Caution must be used 
when comparing levels of adherence between studies, as any 
differences in results may be due to the differing deﬁ  nitions 
of, or methods used to measure adherence rather than any true 
difference in adherence itself (Gao and Nau 2000; Ostrop et al 
2000). This study deﬁ  ned adherence as an ‘all or nothing’ 
principle which could lead to an inﬂ  ation of nonadherence 
levels compared to other studies that classify taking less than 
80% of medications as nonadherence (Gao and Nau 2000; 
Ostrop et al 2000; Chisholm et al 2001).
The high level of self-reported adherence identiﬁ  ed in this 
study could also possibly be described by the Health Belief 
Model (Kiley et al 1993; Gao et al 2000; Poss 2001) which 
proposes that a patient’s adherence behaviour is dependent 
on their perceptions regarding their susceptibility to the dis-
ease, disease severity, beneﬁ  ts of treating the disease, and 
barriers to following the required regimen. The participants 
had strong opinions about their IS medications and condition, 
with the majority strongly agreeing that their IS medications 
were essential to the survival of their transplanted organ and 
future health. This is important, as a patient’s beliefs about 
their medication (Greenstein and Siegal 1998; Horne and 
Weinman 1999) and their condition (Poss 2001) have been 
shown to play an important role in adherence to chronic 
therapy. The more the patient believes their condition would 
deteriorate as a result of not taking their medications as pre-
scribed, the more likely they would be adherent (Horne and 
Weinman 1999; Gao et al 2000).
Encouraging results were found with 94% of the study 
sample displaying positive feelings towards their transplant 
and all participants having a positive feeling towards the 
transplant team. The literature shows that positive feelings 
to the transplant in general (Evenson and Fleury 2000) and 
positive relationships with physicians (Kiley et al 1993; 
Raiz et al 1999) have been shown to have a positive impact 
on adherence, a possible factor contributing to the high 
adherence levels observed in this study.
The level of adherence reported in this study could also 
be reﬂ  ective of the use of a self-reported questionnaire 
to measure adherence. Studies show that patients tend to 
overestimate their own adherence (Svarstad et al 1999; Gao 
and Nau 2000; Ostrop et al 2000) in an attempt to please 
their doctors (Horne and Weinman 1999). Self-reported 
measures of adherence are also subject to recall bias (Horne 
and Weinman 1999; Gao and Nau 2000), selective reporting 
(Rovelli et al 1989; Horne and Weinman 1999), and social 
desirability bias (Gao and Nau 2000).
Frazier and colleagues (1994) found that the most 
commonly cited reason for missing a medication by renal 
transplant recipients was forgetting, followed by being busy 
with other things. These ﬁ  ndings were mirrored in this study, 
which suggests that there are indeed similarities between 
the different solid organ transplant groups regarding factors 
affecting medication adherence.
Previous studies have found that the potential for, or 
actual occurrence of, adverse effects can lead to under-
adherence to a treatment regimen (Haynes et al 1979; Rovelli 
et al 1989; Gao et al 2000; Ostrop et al 2000). This study 
however showed that only 2 or 6.1% of the participants who 
admitted to being bothered by a medication missed a dose as 
a result. This may be a consequence of the understanding, 
exhibited by the participants, as to the potential consequences 
associated with not taking their IS medications.
Kory (1999) reported that most patients used at least 
one strategy or device to facilitate adherence, with the most 
common method being to place medications in a noticeable 
position. This study demonstrated similar ﬁ  ndings.
No differences were found between the patient char-
acteristics, or adherence levels, of in-patients compared to 
out-patients in this study. This could possibly be due to the 
small sample size, rather than consistency between the two 
groups. There is no research in the literature discriminating 
between these two patient groups. Factors affecting adher-
ence may be different for these two groups.
Limitations
There are speciﬁ  c limitations associated with the study instru-
ment. Assessment of adherence is difﬁ  cult because there is 
no gold standard for measurement (Raiz et al 1999). Self-
reported measures, including questionnaires, overestimate the 
patient’s adherence (Kiley et al 1993; Horne and Weinman 
1999; Ostrop et al 2000) and are subject to recall bias (Horne 
and Weinman 1999; Poss 2001) and selective reporting 
(Greenstein and Siegal 1998; Horne and Weinman 1999). 
Direct measures of adherence are more reliable (Osterberg 
and Blaschke 2005), which was not possible in this study.
Conclusion
The level of nonadherence reported in this study was low, 
with the main contributor reported to be ‘forgetfulness’ and 
‘being busy with other things’. The low level of nonadher-
ence seen could possibly be explained by the participants’ 
strong opinions about their IS medications and condition. Patient Preference and Adherence 2008:2 120
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Participants commonly used strategies to facilitate adherence, 
in particular, placing medications in an obvious place to act 
as a reminder to medication taking.
Patients’ opinions about their immunosuppressant 
medications, their condition and transplant experience may 
strongly inﬂ  uence adherence. Health professionals should be 
cognizant of not only the barriers but also the facilitators or 
motivators which can inﬂ  uence adherence, and which can be 
targeted to enhance patient adherence to therapy. The ﬁ  ndings 
of this study have been used in educating pharmacists and 
other clinicians in this area to better care for their patients, 
in particular, in optimizing adherence to therapy.
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